Showing 296 results
  • Preview Image of the Cell and Gene Key Focus Areas Infographic
    PDF
    lock
    Science & Innovation / Infographic
    Cell and gene key focus areas

    At Novartis, we are reimagining medicine to produce breakthroughs and address major unmet needs for patients with devastating diseases, including genetic disorders and certain deadly cancers. These efforts are done in collaboration with scientists, physicians, academia, industry partners, and patients.

  • Preview image of the new era medicine infographic
    PDF
    lock
    Science & Innovation / Infographic
    A new era of medicine

    Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life

  • SWAY Infographic Preview
    PDF
    lock
    Disease Awareness / Infographic
    The Sickle Cell World Assessment Survey (SWAY) results

    The Sickle Cell World Assessment Survey (SWAY) uncovers the impact this disease has on patients and their families.

  • WEF Cancer Map
    PDF
    lock
    Disease Awareness / Infographic
    Cancer 2030: A growing global crisis

    Cancer 2030: A growing global crisis. This infographic shows the projected cancer cases by region.

  • Young Malaria Patient
    Image
    lock
    Malaria Initiative / Image
    Young Malaria Patient

    A young malaria patient being given a dose of pediatric antimalarial medicine at the AMREF Clinic in the Kibera area of Nairobi, Kenya.

  • Worldwide Distribution Center for the Novartis Antimalarial in Basel, Switzerland
    Image
    lock
    Manufacturing / Image
    Worldwide Distribution Center for the Novartis Antimalarial in Basel, Switzerland

    Worldwide distribution center for the Novartis antimalarial in Basel, Switzerland: an employee checks a shipment headed for Mozambique for the US Presidential Malaria Initiative.

  • View of the Fabrikstrasse, Novartis HQ
    Image
    lock
    Locations / Image
    View of the Fabrikstrasse, Novartis HQ
  • T-Cell arrival
    Image
    lock
    Science & Innovation / Image
    T-Cell arrival at the Novartis manufacturing facility

    A cancer patient's frozen T-Cells arrive at a Novartis facility to be reengineered.

  • SMS for Life Training Session
    Image
    lock
    Novartis Social Business / Image
    SMS for Life Training Session

    SMS for Life training session teaching healthcare workers how to use text messaging to monitor stock levels of life-saving antimalarials. In Kenya, Machacos district, SMS for Life also includes patient surveillance data on the testing of malaria patients and the use of artemisinin-based combination therapies (ACTs).

  • SMS for Life
    Image
    lock
    Novartis Social Business / Image
    SMS for Life

    SMS for Life is an innovative public-private partnership led by Novartis under the umbrella of the Roll Back Malaria Partnership. The program has been rolled out across Tanzania and pilots are taking place in Ghana and Kenya.

  • Patient's frozen T-Cells
    Image
    lock
    Science & Innovation / Image
    Patient's frozen T-Cells

    The Frozen T-Cells of a cancer patient.

  • Graphic on Mode of Action of a CGRP Receptor Blocker
    Image
    lock
    Science & Innovation / Image
    Mode of Action of a CGRP Receptor Blocker

    Mode of Action of a CGRP Receptor Blocker, calcitonin gene-related peptide (CGRP), CGRP receptor complex, CGRP receptor blocker targeting the receptor complex.